Highlights of trials conducted by CECOG

Disease indication Protocol Phase Number of pts Number of sites Services provided
Breast, recurrent  or metastatic CECOG/ BC1.3.005 III 560 55 Protocol development, site contracting, statistical analysis, medical writing, drug supply, monitoring, pharmacovigilance
Breast, metastatic CECOG­-BM1 III 259 30 Protocol development, site contracting, statistical analysis, medical writing, drug supply, monitoring, pharmacovigilance
Breast, metastatic CECOG/ BC1.3.002 III 100 14 Protocol development, site contracting, monitoring, pharmacovigilance
Breast, adjuvant CECOG/ BC2.2.005 II 50 3 Protocol development, site contracting, medical writing, statistical analysis, drug supply, monitoring, pharmacovigilance
Lung, NSCLC CECOG/ NSCLC2.2.001 II 80 6 Protocol development, site contracting, statistical analysis, drug supply, monitoring, pharmacovigilance
Lung, NSCLC NSCLC 1 II 352 24 Protocol development, site contracting,  drug supply, monitoring, pharmacovigilance
Colorectal CORE1.2.001  II 150 25 Protocol development, site contracting, statistical analysis, drug supply, monitoring, pharmacovigilance
Colorectal CORE.1.2.002 II 150 22 Protocol development, site contracting, statistical analysis, medical writing, drug supply, monitoring, pharmacovigilance
GIST GIST 1.2.001 III 125 18 Protocol development, site contracting,  drug supply, monitoring, pharmacovigilance
Prostate CECOG/
Prostate 1.2.001
III 376 51 Protocol development, site contracting, drug supply, monitoring

CECOG participated in the following trials

Disease indication Protocol Phase Number of pts from CECOG Number of sites Cooperative Partners Services provided
Lung, NSCLC H3E-MC­JMEN III 168 14 Protocol development,
site contracting,
monitoring
Pancreas CECOG/PAN
1.3.001, SAKK44/00
III 57 3 SAKK,
Switzerland
Protocol development, site contracting, medical writing
Colorectal, metastatic DREAM­M018420 III 50 5 GERCOR, France Protocol development, site contracting, drug supply, monitoring, pharmacovigilance

Prof. Zielinski on Clinical Trials

CECOG Contact Information

Please feel free to contact us if you have any questions.

  • by phone: +43/1/409 77 25

  • christiane.thallinger@cancer-center.cc

  • or fill in the form on contact page